HomeAI · summaries
Storia in 2 fonti
Emcure Pharma net profit up 36% at Rs 292 crore
Emcure Pharmaceuticals reported a 23% revenue increase in the first quarter. Ebitda grew 25.8% with improved margins, reflecting productivity gains. Net profit saw a significant 36.2% rise during the period. The company began its five-year plan on a strong footing for FY27. Emcure also completed the acquisition of a minority stake in Gennova Biopharmaceuticals.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
thehindubusinessline.com
Emcure Pharmaceuticals Q1 profit rises 36% at ₹292.5 crore
Emcure Pharmaceuticals reports a 36% profit increase to ₹292.5 crore in Q1, driven by strong international business growth.
- ·
economictimes.indiatimes.com
Emcure Pharma Q1 profit jumps 36%, revenue rises 23%; appoints Samit Mehta as COO
"We have begun FY27, the second year of our five-year plan—on a strong footing. FY26 was about putting the building blocks in place across teams, portfolio, integration and…
